AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 201 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,174,005 | +66.4% | 41,455 | +34.9% | 0.01% | +66.7% |
| Q1 2023 | $705,615 | -52.0% | 30,719 | -41.3% | 0.00% | -70.0% |
| Q4 2022 | $1,469,033 | -99.6% | 52,316 | +294.1% | 0.01% | +233.3% |
| Q3 2022 | $375,388,000 | -68.7% | 13,274 | -61.2% | 0.00% | -80.0% |
| Q3 2020 | $1,198,190,000 | +60.7% | 34,234 | +145.6% | 0.02% | +25.0% |
| Q2 2020 | $745,564,000 | +156860.8% | 13,941 | +4.0% | 0.01% | +71.4% |
| Q1 2020 | $475,000 | -43.8% | 13,400 | -24.3% | 0.01% | 0.0% |
| Q4 2019 | $845,000 | +59.1% | 17,705 | +8.1% | 0.01% | +40.0% |
| Q3 2019 | $531,000 | -89.7% | 16,374 | -81.4% | 0.01% | -88.4% |
| Q1 2017 | $5,150,000 | +2.1% | 88,185 | -7.7% | 0.04% | -6.5% |
| Q3 2016 | $5,045,000 | +303.6% | 95,510 | +220.0% | 0.05% | +283.3% |
| Q2 2016 | $1,250,000 | -82.5% | 29,847 | -70.5% | 0.01% | -85.0% |
| Q3 2015 | $7,151,000 | +215.3% | 101,299 | +396.3% | 0.08% | +175.9% |
| Q2 2015 | $2,268,000 | – | 20,411 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rock Springs Capital Management LP | 2,661,605 | $61,137,067 | 1.46% |
| Bellevue Group AG | 4,013,500 | $92,190,095 | 1.34% |
| Eagle Health Investments LP | 267,630 | $6,147,461 | 1.20% |
| ARMISTICE CAPITAL, LLC | 3,460,000 | $79,476,200 | 1.14% |
| Integral Health Asset Management, LLC | 213,000 | $4,892,610 | 0.99% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 454,000 | $10,428,380 | 0.44% |
| ArrowMark Colorado Holdings LLC | 1,557,705 | $35,780,484 | 0.41% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,092,829 | $48,072,282 | 0.27% |
| Virtus ETF Advisers LLC | 9,932 | $228,138 | 0.13% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 614,533 | $14,115,823 | 0.09% |